Trial Outcomes & Findings for Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP) (NCT NCT01152762)
NCT ID: NCT01152762
Last Updated: 2026-08-06
Results Overview
The questionnaire is designed to measure the impact of respiratory symptoms and their treatment on a patient's daily life. It consists of various sections that cover a range of topics related to respiratory health, including symptoms, activity limitations, and overall well-being. The SGRQ questionnaire has 50 items with 76 weighted responses. Scores range from 0 to 100, with higher scores indicating more limitations.
COMPLETED
NA
129 participants
Six months
2026-08-06
Participant Flow
Participant milestones
| Measure |
Control Group
Normal primary care treatment
|
Standardized Respiratory Physiotherapy
Standardized Respiratory Physiotherapy is the intervention in all selected patients
|
|---|---|---|
|
Overall Study
STARTED
|
64
|
65
|
|
Overall Study
COMPLETED
|
60
|
62
|
|
Overall Study
NOT COMPLETED
|
4
|
3
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP)
Baseline characteristics by cohort
| Measure |
Control Group
n=64 Participants
Normal primary care treatment
|
Total
n=129 Participants
Total of all reporting groups
|
Standardized Respiratory Physiotherapy
n=65 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
0 Participants
n=20 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
26 Participants
n=20 Participants
|
51 Participants
n=40 Participants
|
25 Participants
n=20 Participants
|
|
Age, Categorical
>=65 years
|
38 Participants
n=20 Participants
|
78 Participants
n=40 Participants
|
40 Participants
n=20 Participants
|
|
Age, Continuous
|
59.8 years
STANDARD_DEVIATION 9.1 • n=20 Participants
|
60.4 years
STANDARD_DEVIATION 8.3 • n=40 Participants
|
60.8 years
STANDARD_DEVIATION 7.8 • n=20 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=20 Participants
|
35 Participants
n=40 Participants
|
14 Participants
n=20 Participants
|
|
Sex: Female, Male
Male
|
43 Participants
n=20 Participants
|
94 Participants
n=40 Participants
|
51 Participants
n=20 Participants
|
|
Region of Enrollment
Spain
|
64 participants
n=20 Participants
|
129 participants
n=40 Participants
|
65 participants
n=20 Participants
|
PRIMARY outcome
Timeframe: Six monthsPopulation: 7 participants were excluded from the analysis
The questionnaire is designed to measure the impact of respiratory symptoms and their treatment on a patient's daily life. It consists of various sections that cover a range of topics related to respiratory health, including symptoms, activity limitations, and overall well-being. The SGRQ questionnaire has 50 items with 76 weighted responses. Scores range from 0 to 100, with higher scores indicating more limitations.
Outcome measures
| Measure |
Standardized Respiratory Physiotherapy
n=62 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
|
Control Group
n=60 Participants
Usual clinical practice
|
|---|---|---|
|
St-George Respiratory Questionnaire-SGRQ
|
29.6 score on a scale
Standard Deviation 20.5
|
38 score on a scale
Standard Deviation 21.1
|
PRIMARY outcome
Timeframe: 6 monthThe BODE index is a clinical tool used to assess the severity of chronic obstructive pulmonary disease (COPD) and predict the risk of mortality in individuals with this respiratory condition. The BODE Index is a 0 to 10-point scale and it is based on four factors: * Body Mass Index (BMI) * Airflow obstruction (FEV1, as a percentage of the predicted value) * Dyspnea (measured using the MRC dyspnea scale, which ranges from 0 to 4) * Exercise capacity (measured by the 6-minute walk test, in meters) Each factor is assigned a score from 0 to 3 (except for BMI, which can only receive 0 or 1). The total score ranges from 0 to 10, with higher values indicating greater severity and a worse prognosis for COPD.
Outcome measures
| Measure |
Standardized Respiratory Physiotherapy
n=62 Participants
Standardized Respiratory Physiotherapy is the intervention in all selected patients
|
Control Group
n=60 Participants
Usual clinical practice
|
|---|---|---|
|
BODE Index
|
1.52 score on a scale
Standard Deviation 1.35
|
1.77 score on a scale
Standard Deviation 1.47
|
Adverse Events
Standardized Respiratory Physiotherapy
Control Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Maria Montserrat Inglés Novell
Catalan Health Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place